Cardiovascular	B:C3887460
comorbidity	O
in	O
patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
in	O
the	O
Canary	O
Islands	I:C0454662
(	O
CCECAN	O
study	I:C0008972
)	O
.	O

Cardiovascular	O
comorbidity	O
in	O
patients	O
with	O
chronic	B:C0024117
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
in	O
the	O
Canary	O
Islands	I:C0454662
(	O
CCECAN	O
study	I:C0008972
)	O
.	O

Cardiovascular	O
comorbidity	O
in	O
patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
in	O
the	O
Canary	B:C0454662
Islands	I:C0454662
(	O
CCECAN	O
study	I:C0008972
)	O
.	O

Cardiovascular	O
comorbidity	O
in	O
patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
in	O
the	O
Canary	O
Islands	I:C0454662
(	O
CCECAN	B:C0008972
study	I:C0008972
)	O
.	O

Numerous	O
studies	B:C0947630
have	O
shown	O
a	O
high	O
prevalence	O
of	O
cardiovascular	O
disease	I:C0007222
in	O
patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
(	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
)	O
.	O

Numerous	O
studies	O
have	O
shown	O
a	O
high	O
prevalence	O
of	O
cardiovascular	B:C0007222
disease	I:C0007222
in	O
patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
(	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
)	O
.	O

Numerous	O
studies	O
have	O
shown	O
a	O
high	O
prevalence	O
of	O
cardiovascular	O
disease	I:C0007222
in	O
patients	O
with	O
chronic	B:C0024117
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
(	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
)	O
.	O

Numerous	O
studies	O
have	O
shown	O
a	O
high	O
prevalence	O
of	O
cardiovascular	O
disease	I:C0007222
in	O
patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
(	O
chronic	B:C0024117
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
)	O
.	O

The	O
aim	O
of	O
this	O
study	B:C0008972
was	O
to	O
analyse	O
the	O
prevalence	O
of	O
cardiovascular	O
risk	O
factors	O
and	O
comorbidity	O
in	O
a	O
Canary	O
Islands	I:C0454662
population	O
diagnosed	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
,	O
and	O
compared	O
it	O
with	O
data	O
from	O
the	O
general	O
population	I:C0683971
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyse	O
the	O
prevalence	O
of	O
cardiovascular	O
risk	O
factors	O
and	O
comorbidity	O
in	O
a	O
Canary	B:C0454662
Islands	I:C0454662
population	O
diagnosed	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
,	O
and	O
compared	O
it	O
with	O
data	O
from	O
the	O
general	O
population	I:C0683971
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyse	O
the	O
prevalence	O
of	O
cardiovascular	O
risk	O
factors	O
and	O
comorbidity	O
in	O
a	O
Canary	O
Islands	I:C0454662
population	O
diagnosed	B:C0011900
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
,	O
and	O
compared	O
it	O
with	O
data	O
from	O
the	O
general	O
population	I:C0683971
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyse	O
the	O
prevalence	O
of	O
cardiovascular	O
risk	O
factors	O
and	O
comorbidity	O
in	O
a	O
Canary	O
Islands	I:C0454662
population	O
diagnosed	O
with	O
chronic	B:C0024117
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
,	O
and	O
compared	O
it	O
with	O
data	O
from	O
the	O
general	O
population	I:C0683971
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyse	O
the	O
prevalence	O
of	O
cardiovascular	O
risk	O
factors	O
and	O
comorbidity	O
in	O
a	O
Canary	O
Islands	I:C0454662
population	O
diagnosed	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
,	O
and	O
compared	O
it	O
with	O
data	O
from	O
the	O
general	B:C0683971
population	I:C0683971
.	O

A	O
cross-sectional	B:C0010362
study	I:C0010362
was	O
carried	O
out	O
in	O
300	O
patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
and	O
524	O
subjects	O
without	O
respiratory	O
disease	I:C0035242
(	O
control	O
group	O
)	O
.	O

A	O
cross-sectional	O
study	I:C0010362
was	O
carried	O
out	O
in	O
300	O
patients	O
with	O
chronic	B:C0024117
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
and	O
524	O
subjects	O
without	O
respiratory	O
disease	I:C0035242
(	O
control	O
group	O
)	O
.	O

A	O
cross-sectional	O
study	I:C0010362
was	O
carried	O
out	O
in	O
300	O
patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
and	O
524	O
subjects	B:C0080105
without	O
respiratory	O
disease	I:C0035242
(	O
control	O
group	O
)	O
.	O

A	O
cross-sectional	O
study	I:C0010362
was	O
carried	O
out	O
in	O
300	O
patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
and	O
524	O
subjects	O
without	O
respiratory	B:C0035242
disease	I:C0035242
(	O
control	O
group	O
)	O
.	O

The	O
two	O
groups	B:C1257890
were	O
compared	O
using	O
standard	O
bivariate	O
methods	O
.	O

Logistic	O
regression	O
models	O
were	O
used	O
to	O
estimate	O
the	O
cardiovascular	O
risks	O
in	O
chronic	B:C0024117
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
patients	O
compared	O
to	O
control	O
group	O
.	O

Patients	O
with	O
chronic	B:C0024117
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
showed	O
a	O
high	O
prevalence	O
of	O
hypertension	O
(	O
72	O
%	O
)	O
,	O
dyslipidaemia	O
(	O
73	O
%	O
)	O
,	O
obesity	O
(	O
41	O
%	O
)	O
,	O
diabetes	O
type	I:C0011860
2	I:C0011860
(	O
39	O
%	O
)	O
,	O
and	O
sleep	O
apnoea	I:C0037315
syndrome	I:C0037315
(	O
30	O
%	O
)	O
from	O
mild	O
stages	O
of	O
the	O
disease	O
(	O
GOLD	O
2009	O
)	O
.	O

Patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
showed	O
a	O
high	O
prevalence	O
of	O
hypertension	B:C0020538
(	O
72	O
%	O
)	O
,	O
dyslipidaemia	O
(	O
73	O
%	O
)	O
,	O
obesity	O
(	O
41	O
%	O
)	O
,	O
diabetes	O
type	I:C0011860
2	I:C0011860
(	O
39	O
%	O
)	O
,	O
and	O
sleep	O
apnoea	I:C0037315
syndrome	I:C0037315
(	O
30	O
%	O
)	O
from	O
mild	O
stages	O
of	O
the	O
disease	O
(	O
GOLD	O
2009	O
)	O
.	O

Patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
showed	O
a	O
high	O
prevalence	O
of	O
hypertension	O
(	O
72	O
%	O
)	O
,	O
dyslipidaemia	B:C0242339
(	O
73	O
%	O
)	O
,	O
obesity	O
(	O
41	O
%	O
)	O
,	O
diabetes	O
type	I:C0011860
2	I:C0011860
(	O
39	O
%	O
)	O
,	O
and	O
sleep	O
apnoea	I:C0037315
syndrome	I:C0037315
(	O
30	O
%	O
)	O
from	O
mild	O
stages	O
of	O
the	O
disease	O
(	O
GOLD	O
2009	O
)	O
.	O

Patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
showed	O
a	O
high	O
prevalence	O
of	O
hypertension	O
(	O
72	O
%	O
)	O
,	O
dyslipidaemia	O
(	O
73	O
%	O
)	O
,	O
obesity	B:C0028754
(	O
41	O
%	O
)	O
,	O
diabetes	O
type	I:C0011860
2	I:C0011860
(	O
39	O
%	O
)	O
,	O
and	O
sleep	O
apnoea	I:C0037315
syndrome	I:C0037315
(	O
30	O
%	O
)	O
from	O
mild	O
stages	O
of	O
the	O
disease	O
(	O
GOLD	O
2009	O
)	O
.	O

Patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
showed	O
a	O
high	O
prevalence	O
of	O
hypertension	O
(	O
72	O
%	O
)	O
,	O
dyslipidaemia	O
(	O
73	O
%	O
)	O
,	O
obesity	O
(	O
41	O
%	O
)	O
,	O
diabetes	B:C0011860
type	I:C0011860
2	I:C0011860
(	O
39	O
%	O
)	O
,	O
and	O
sleep	O
apnoea	I:C0037315
syndrome	I:C0037315
(	O
30	O
%	O
)	O
from	O
mild	O
stages	O
of	O
the	O
disease	O
(	O
GOLD	O
2009	O
)	O
.	O

Patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
showed	O
a	O
high	O
prevalence	O
of	O
hypertension	O
(	O
72	O
%	O
)	O
,	O
dyslipidaemia	O
(	O
73	O
%	O
)	O
,	O
obesity	O
(	O
41	O
%	O
)	O
,	O
diabetes	O
type	I:C0011860
2	I:C0011860
(	O
39	O
%	O
)	O
,	O
and	O
sleep	B:C0037315
apnoea	I:C0037315
syndrome	I:C0037315
(	O
30	O
%	O
)	O
from	O
mild	O
stages	O
of	O
the	O
disease	O
(	O
GOLD	O
2009	O
)	O
.	O

There	O
was	O
a	O
22	O
%	O
prevalence	O
of	O
cardiac	B:C0003811
arrhythmia	I:C0003811
,	O
16	O
%	O
of	O
ischaemic	O
heart	I:C0010068
disease	I:C0010068
,	O
16	O
%	O
heart	O
failure	I:C0018801
,	O
12	O
%	O
peripheral	O
vascular	I:C0085096
disease	I:C0085096
,	O
and	O
8	O
%	O
cerebrovascular	O
disease	I:C0007820
.	O

There	O
was	O
a	O
22	O
%	O
prevalence	O
of	O
cardiac	O
arrhythmia	I:C0003811
,	O
16	O
%	O
of	O
ischaemic	B:C0010068
heart	I:C0010068
disease	I:C0010068
,	O
16	O
%	O
heart	O
failure	I:C0018801
,	O
12	O
%	O
peripheral	O
vascular	I:C0085096
disease	I:C0085096
,	O
and	O
8	O
%	O
cerebrovascular	O
disease	I:C0007820
.	O

There	O
was	O
a	O
22	O
%	O
prevalence	O
of	O
cardiac	O
arrhythmia	I:C0003811
,	O
16	O
%	O
of	O
ischaemic	O
heart	I:C0010068
disease	I:C0010068
,	O
16	O
%	O
heart	B:C0018801
failure	I:C0018801
,	O
12	O
%	O
peripheral	O
vascular	I:C0085096
disease	I:C0085096
,	O
and	O
8	O
%	O
cerebrovascular	O
disease	I:C0007820
.	O

There	O
was	O
a	O
22	O
%	O
prevalence	O
of	O
cardiac	O
arrhythmia	I:C0003811
,	O
16	O
%	O
of	O
ischaemic	O
heart	I:C0010068
disease	I:C0010068
,	O
16	O
%	O
heart	O
failure	I:C0018801
,	O
12	O
%	O
peripheral	B:C0085096
vascular	I:C0085096
disease	I:C0085096
,	O
and	O
8	O
%	O
cerebrovascular	O
disease	I:C0007820
.	O

There	O
was	O
a	O
22	O
%	O
prevalence	O
of	O
cardiac	O
arrhythmia	I:C0003811
,	O
16	O
%	O
of	O
ischaemic	O
heart	I:C0010068
disease	I:C0010068
,	O
16	O
%	O
heart	O
failure	I:C0018801
,	O
12	O
%	O
peripheral	O
vascular	I:C0085096
disease	I:C0085096
,	O
and	O
8	O
%	O
cerebrovascular	B:C0007820
disease	I:C0007820
.	O

Compared	O
to	O
the	O
control	O
group	O
,	O
patients	O
with	O
chronic	B:C0024117
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
had	O
a	O
higher	O
risk	O
of	O
dyslipidaemia	O
(	O
OR	O
3.24	O
,	O
95	O
%	O
CI	O
;	O
2.21	O
-4.75	O
)	O
,	O
diabetes	O
type	I:C0011860
2	I:C0011860
(	O
OR	O
1.52	O
,	O
95	O
%	O
CI	O
;	O
1.01	O
-	O
2,28	O
)	O
,	O
and	O
ischaemic	O
heart	I:C0010068
disease	I:C0010068
(	O
OR	O
2.34	O
,	O
95	O
%	O
CI	O
;	O
1.22-4.49	O
)	O
.	O

Compared	O
to	O
the	O
control	O
group	O
,	O
patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
had	O
a	O
higher	O
risk	O
of	O
dyslipidaemia	B:C0242339
(	O
OR	O
3.24	O
,	O
95	O
%	O
CI	O
;	O
2.21	O
-4.75	O
)	O
,	O
diabetes	O
type	I:C0011860
2	I:C0011860
(	O
OR	O
1.52	O
,	O
95	O
%	O
CI	O
;	O
1.01	O
-	O
2,28	O
)	O
,	O
and	O
ischaemic	O
heart	I:C0010068
disease	I:C0010068
(	O
OR	O
2.34	O
,	O
95	O
%	O
CI	O
;	O
1.22-4.49	O
)	O
.	O

Compared	O
to	O
the	O
control	O
group	O
,	O
patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
had	O
a	O
higher	O
risk	O
of	O
dyslipidaemia	O
(	O
OR	O
3.24	O
,	O
95	O
%	O
CI	O
;	O
2.21	O
-4.75	O
)	O
,	O
diabetes	B:C0011860
type	I:C0011860
2	I:C0011860
(	O
OR	O
1.52	O
,	O
95	O
%	O
CI	O
;	O
1.01	O
-	O
2,28	O
)	O
,	O
and	O
ischaemic	O
heart	I:C0010068
disease	I:C0010068
(	O
OR	O
2.34	O
,	O
95	O
%	O
CI	O
;	O
1.22-4.49	O
)	O
.	O

Compared	O
to	O
the	O
control	O
group	O
,	O
patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
had	O
a	O
higher	O
risk	O
of	O
dyslipidaemia	O
(	O
OR	O
3.24	O
,	O
95	O
%	O
CI	O
;	O
2.21	O
-4.75	O
)	O
,	O
diabetes	O
type	I:C0011860
2	I:C0011860
(	O
OR	O
1.52	O
,	O
95	O
%	O
CI	O
;	O
1.01	O
-	O
2,28	O
)	O
,	O
and	O
ischaemic	B:C0010068
heart	I:C0010068
disease	I:C0010068
(	O
OR	O
2.34	O
,	O
95	O
%	O
CI	O
;	O
1.22-4.49	O
)	O
.	O

In	O
the	O
case	O
of	O
dyslipidaemia	B:C0242339
,	O
an	O
increased	O
risk	O
was	O
obtained	O
when	O
adjusted	O
for	O
age	O
,	O
gender	O
,	O
and	O
consumption	O
of	O
tobacco	O
(	O
OR	O
5.04	O
,	O
95	O
%	O
CI	O
;	O
2.36	O
-10.74	O
)	O
.	O

Patients	O
with	O
chronic	B:C0024117
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
resident	O
in	O
the	O
Canary	O
Islands	I:C0454662
have	O
a	O
high	O
prevalence	O
of	O
hypertension	O
,	O
dyslipidaemia	O
,	O
ischaemic	O
heart	I:C0010068
disease	I:C0010068
,	O
and	O
cardiac	O
arrhythmia	I:C0003811
.	O

Patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
resident	B:C2347958
in	O
the	O
Canary	O
Islands	I:C0454662
have	O
a	O
high	O
prevalence	O
of	O
hypertension	O
,	O
dyslipidaemia	O
,	O
ischaemic	O
heart	I:C0010068
disease	I:C0010068
,	O
and	O
cardiac	O
arrhythmia	I:C0003811
.	O

Patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
resident	O
in	O
the	O
Canary	B:C0454662
Islands	I:C0454662
have	O
a	O
high	O
prevalence	O
of	O
hypertension	O
,	O
dyslipidaemia	O
,	O
ischaemic	O
heart	I:C0010068
disease	I:C0010068
,	O
and	O
cardiac	O
arrhythmia	I:C0003811
.	O

Patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
resident	O
in	O
the	O
Canary	O
Islands	I:C0454662
have	O
a	O
high	O
prevalence	O
of	O
hypertension	B:C0020538
,	O
dyslipidaemia	O
,	O
ischaemic	O
heart	I:C0010068
disease	I:C0010068
,	O
and	O
cardiac	O
arrhythmia	I:C0003811
.	O

Patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
resident	O
in	O
the	O
Canary	O
Islands	I:C0454662
have	O
a	O
high	O
prevalence	O
of	O
hypertension	O
,	O
dyslipidaemia	B:C0242339
,	O
ischaemic	O
heart	I:C0010068
disease	I:C0010068
,	O
and	O
cardiac	O
arrhythmia	I:C0003811
.	O

Patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
resident	O
in	O
the	O
Canary	O
Islands	I:C0454662
have	O
a	O
high	O
prevalence	O
of	O
hypertension	O
,	O
dyslipidaemia	O
,	O
ischaemic	B:C0010068
heart	I:C0010068
disease	I:C0010068
,	O
and	O
cardiac	O
arrhythmia	I:C0003811
.	O

Patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
resident	O
in	O
the	O
Canary	O
Islands	I:C0454662
have	O
a	O
high	O
prevalence	O
of	O
hypertension	O
,	O
dyslipidaemia	O
,	O
ischaemic	O
heart	I:C0010068
disease	I:C0010068
,	O
and	O
cardiac	B:C0003811
arrhythmia	I:C0003811
.	O

Compared	O
to	O
general	B:C0683971
population	I:C0683971
,	O
patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
have	O
a	O
significant	O
increase	O
in	O
the	O
risk	O
of	O
dyslipidaemia	O
.	O

Compared	O
to	O
general	O
population	I:C0683971
,	O
patients	O
with	O
chronic	B:C0024117
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
have	O
a	O
significant	O
increase	O
in	O
the	O
risk	O
of	O
dyslipidaemia	O
.	O

Compared	O
to	O
general	O
population	I:C0683971
,	O
patients	O
with	O
chronic	O
obstructive	I:C0024117
pulmonary	I:C0024117
disease	I:C0024117
have	O
a	O
significant	O
increase	O
in	O
the	O
risk	O
of	O
dyslipidaemia	B:C0242339
.	O

